Another one say generic Arixtra had about 10% in Early Nov.
http://www.financialexpress.com/news/booster-from-bulk-drugs/871959/3
Dr Reddy's Lab-Rating: Overweight
Booster from bulk drugs
Posted: Monday, Nov 07, 2011 at 0618 hrs IST
Tags: HSBC | SG&A Growth | Drug-maker | OTC
under the head of raw materials.
Fondaparinux (generic Arixtra) has a current US market share of about 10% and the company expects it to garner more market share after the scaling up of the manufacturing capacity and the addressing of the packaging issues.
- Forums
- ASX - By Stock
- TSN
- shares on issue
shares on issue, page-75
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable